top of page

November 2022
Congratulations to Manuel for his artwork on the cover of Trends in Parasitology

Our new review together with Mathieu Cayla and Keith Matthews, "Distinguishing functions of trypanosomatid protein kinases", showcases the activity of protein kinases that are required for successful life cycle transitions in trypanosomatid parasitic protozoa.  Congratulations to Romina for the extensive comparative analysis shown in figure 1.

24th March 2022
60th Anniversary BSP Spring meeting

Lab members enjoying the conference dinner at Castle Howard

Our new article, "Targeting the trypanosome kinetochore with CLK1 protein kinase inhibitors", showcases recent work into the mechanism of action of AB1, an inhibitor with potent activity against Trypanosoma brucei bloodstream forms, Leishmania and Trypanosoma cruzi. 

For the course, Nathaniel Jones and Nicola Baker gave a practical demonstration of CRISPR-Cas9 editing in Leishmania.


Regarding the course, Professor Mottram said: “CRIPSR genome editing transforms how we identify and validate new drug targets for neglected tropical diseases, such as leishmaniasis. The workshop in Kolkata provided theoretical and hands-on training in Leishmania gene manipulation, allowing students to extend the technology into their own research programs.  The success of the workshops in Rio de Janeiro and Kolkata are inspiring us to hold further training for researchers from developing countries.”

Please reload

CII and Mottram group representation at WorldLeish 2017

Scientists at the University of York and Hull York Medical School have been awarded two new grants to tackle the parasitic disease leishmaniasis.

One drug can treat three deadly and neglected infections - Chagas disease, leishmaniasis and sleeping sickness.

Please reload

bottom of page